HQH Insider Trading Activity and SEC Form 4 Filings
HQH insider trading summary
Over the past 12 months, insiders at abrdn Healthcare Investors (HQH) reported 1 open-market purchase worth $11K by 1 insider and 1 sale worth $5K by 1 insider on SEC Form 4. Net insider buying was $6K.
Latest HQH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Alan R Goodson | Director | Sell | $5K (242.01 @ $19.32) |
| Jul 16, 2026 | Chris LaVictoire Mahai | Director | Buy | $11K (501 @ $20.96) |
| Jul 16, 2024 | Rose DiMartino | Director | Buy | $19K (1,000 @ $18.88) |
| Apr 9, 2024 | Kathleen Goetz | Director | Buy | $9K (525 @ $16.42) |
| Jan 2, 2024 | Todd Reit | Director | Buy | $17K (1,000 @ $16.93) |
| Dec 28, 2023 | Bill Maher | Director | Buy | $17K (1,000 @ $16.58) |
| Dec 21, 2023 | Alan R Goodson | Vice President | Buy | $3K (170 @ $16.13) |
| Sep 25, 2023 | Daniel R Omstead | President | Buy | $149K (9,500 @ $15.63) |
| Sep 20, 2023 | Daniel R Omstead | President | Buy | $151K (9,500 @ $15.88) |
| Mar 23, 2022 | Kathleen Goetz | Director | Buy | $2K (73.529 @ $20.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.